Authors: de Beer, F van Dijk, KW Jong, MC van Vark, LC van der Zee, A Hofker, MH Fallaux, FJ Hoeben, RC Smelt, AHM Havekes, LM

Citation: F. De Beer et al., Apolipoprotein E2 (Lys146 -> Gln) causes hypertriglyceridemia due to an apolipoprotein E variant-specific inhibition of lipolysis of very low densitylipoproteins-triglycerides, ART THROM V, 20(7), 2000, pp. 1800-1806

Authors: Tacken, PJ de Beer, F van Vark, LC Havekes, LM Hofker, MH van Dijk, KW

Citation: Pj. Tacken et al., Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 isenhanced by lipoprotein lipase, and does not require apolipoprotein E, BIOCHEM J, 347, 2000, pp. 357-361

Authors: de Man, FHAF de Beer, F van der Laarse, A Jansen, H Leuven, JAG Souverijn, JHM Vroom, TFFP Schoormans, SCM Fruchart, JC Havekes, LM Smelt, AHM

Citation: Fhaf. De Man et al., The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia ismediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding, ATHEROSCLER, 153(2), 2000, pp. 363-371

Authors: Ivandic, B Castellani, LW Wang, XP Qiao, JH Mehrabian, M Navab, M Fogelman, AM Grass, DS Swanson, ME de Beer, MC de Beer, F Lusis, AJ

Citation: B. Ivandic et al., Role of group II secretory phospholipase A(2) in atherosclerosis - 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A(2), ART THROM V, 19(5), 1999, pp. 1284-1290

Authors: de Beer, F Hendriks, WL van Vark, LC Kamerling, SWA van Dijk, KW Hofker, MH Smelt, AHM Havekes, LM

Citation: F. De Beer et al., Binding of beta-VLDL to heparan sulfate proteoglycans requires lipoproteinlipase, whereas ApoE only modulates binding affinity, ART THROM V, 19(3), 1999, pp. 633-637